King & Spalding LLP > Frankfurt, Germany > Firm Profile
King & Spalding LLP Offices

TAUNUSTURM
TAUNUSTOR 1
60310 FRANKFURT AM MAIN
Germany
King & Spalding LLP > The Legal 500 Rankings
Banking and finance > Investment funds Tier 2
In the funds sector, King & Spalding LLP has a clear focus on real estate investment funds and advises German and, in particular, international investment fund managers, asset managers, institutional investors and banks. Its advice portfolio ranges from fund launch, structuring and management to transactions and fund liquidation while also including the whole array of related regulatory, tax and compliance issues. Managing partner and founder of the Frankfurt office Mario Leißner heads the practice and comprehensively covers real estate-related investment law issues. He is regularly supported by Alexandra Weis, who combines investment law expertise with regulatory know-how.Practice head(s):
Other key lawyers:
Testimonials
‘We experience the cooperation with King & Spalding LLP as very competent and efficient. Requests are fulfilled within the promised timeframe and are of high quality. Suggestions and comments are solution- and practice-oriented. That’s why we like to be “repeat offenders”.’
‘The cooperation is very goal-oriented, good solutions are worked out that constantly improve the quality of our contracts and legal sales documents. In the course of the projects, we have developed many common themes. It is a very pleasant cooperation, both professionally and personally.’
‘Team with a very clear profile in the investment fund space. Incredibly deep industry knowledge with a high level of practical relevance. Very creative when it comes to meeting demanding regulatory requirements.’
‘Mario Leißner, Alexandra Weis: Both have been in the industry for a long time with a wealth of experience, are willing to look for unusual solutions and implement them in a resilient way.’
‘Above-average knowledge of investment, banking, finance and regulatory law. Focused, efficient and solution-oriented way of working in the interests of the customer.’
‘Alexandra Weis has many years of experience and excellent professional competence. Quality at the highest level.’
Key clients
Hannover Leasing
AEW Invest GmbH
AXA Investment Managers
Tishman Speyer
HansaInvest Hanseatische Investment GmbH
Commerz Real Kapitalverwaltungsgesellschaft mbH
BEOS AG
2IP Institutional Investment Partners
BMO Real Estate Partners
Savills Fund Management GmbH
DWS Alternatives GmbH
RAM Invest
Patrizia Frankfurt Kapitalverwaltungsgesellschaft mbH (ehemals TRIUVA)
Barings Real Estate Advisers
Principal Real Estate Investors (ehemals Internos Global Investors)
RFR Management GmbH
LaSalle Investment Management
La Francçaise
Wertgrund
Colliers
Prudential Financial Inc.
CBRE Global Investors
Doric Investment
Allianz Global Investors
Union Investment
Universal Investment
Warburg-HIH Invest Real Estate
bsi Bundesverband Sachwerte und Investmentvermögen
Ärzteversorgung Westfalen-Lippe
Atlantic Partners (USA)
Bouwfonds Real Estate Investment Managers
Clarion Partners (USA)
Galleon Capital
GRR Real Estate
HIH Global Invest
Hypoport AG
JAMESTOWN US-Immobilien
Oakland Capital
McCafferty Asset Management
KGAL
Work highlights
- Advising AEW Invest GmbH on a €1.3bn fund launch and sale of a residential real estate portfolio with 2,500 residential units to GWH Immobilien Holding.
- Regulatory advice to AXA Investment Managers in connection with non-German real estate transactions, particularly in Scandinavia.
- Advising a fully licensed AIF capital management company on the launch of its first open-end mutual fund with five different share classes for real estate investments in Germany; advice on the preparation of the entire fund documentation as well as approval and distribution permit process at BaFin.
Industry focus > Healthcare and life sciences Tier 3
King & Spalding LLP focuses on regulatory advice in the life sciences space. Practice head Ulf Grundmann and senior associate Elisabeth Kohoutek cover both the interface between pharmaceutical and food law and the regulatory framework for pharmaceuticals and medical devices. In 2020, the health claims regulation, the counterfeit drug directive, including advice on the corresponding trade mark law issues and the representation of Novartis in a market-known ECJ procedure, as well as the regulatory support of transactions were among the practice's core areas. Growth was seen in particular in data protection issues, also in the context of digital health, artificial intelligence and ESG. The German practice regularly cooperates with the US colleagues in the Washington DC office.Practice head(s):
Other key lawyers:
Testimonials
‘Very in-depth knowledge and excellent understanding of client business, combined with creativity and the ability to approach problems from a completely different perspective.’
Key clients
Novartis Pharma AG
ratiopharm GmbH
GlaxoSmithKline Consumer Healthcare GmbH & Co. KG (GSK Consumer Healthcare)
Famous Brands GmbH
Angelini Pharma Deutschland
Pfizer Consumer Healthcare
Teva GmbH Deutschland GmbH
Teva Pharmaceuticals B.V.
Dr. Willmar Schwabe GmbH & Co.KG
Deutsche Homöopathie-Union DHU-Arzneimittel GmbH & Co. KG (DHU)
Roche Diagnostics GmbH
Amy’s Kitchen
VSM Geneesmiddelen B.V.
Chemische Fabrik Kreussler Co. GmbH
Daizu GmbH
Dr. Kade Pharmazeutische Fabrik GmbH
Diagnostic Green
SGF International e.V.
Eckes-Granini Group
AGNovos Healthcare
Truw Arzneimittel GmbH
biomo-vital GmbH
Gamers Only GmbH
Work highlights
- Representing Novartis Pharma AG as the original manufacturer in the first referral procedure before the ECJ on the counterfeit medicines directive.
- Representation of ratiopharm GmbH in proceedings against the parallel import of medicines from ratiopharm to Germany, in particular against the background of the change in medicines law due to the counterfeit medicines directive.
- Advice to GSK Consumer Healthcare in connection with OTC products in competition law disputes and advice in connection with drug, food and medical device law.
Real estate and construction > Real estate Tier 3
King & Spalding LLP focuses on real estate law advice in the area of investment funds. Accordingly, German capital management companies, international investment fund managers, asset managers and German and international institutional real estate investors as well as banks are advised on real estate transactions, their financing and tax-efficient structuring as well as on regulatory issues. This focus is also reflected in the practice group management, which is headed by real estate fund and fund structuring expert Mario Leißner. Alexandra Weis is the central contact for regulatory advice related to real estate funds. The service spectrum includes clients' representation in court as well as in arbitration proceedings.Practice head(s):
Other key lawyers:
Key clients
Hannover Leasing
PATRIZIA
Tishman Speyer
JP Morgan
AXA Investment Managers
BEOS AG
Commerz Real Investmentgesellschaft
AEW Invest GmbH
DekaBank Deutsche Girozentrale
HANSAINVEST Hanseatische Investment-GmbH
Barings
Savills Fund Management
BMO (=Bank of Montréal) Real Estate Partners
Orion Capital Managers
2IP Institutional Investment Partners
PATRIZIA Frankfurt Kapitalverwaltungsgesellschaft mbH
La Francaise
Universal Investment
Union Investment
Principal Real Estate Investors
Proprium Capital
Forte Capital
Bouwfonds
Deka Immobilien GmbH
CBRE Global Investors
Allianz Real Estate
Jamestown
RAM Invest
DIC Asset AG
Warburg-HIH Invest Real Estate
STADT UND LAND Wohnbauten-Gesellschaft mbH
Work highlights
- Advising Hannover Leasing on the purchase of the Weitblick 1.7 office and congress center in Augsburg for a closed domestic special AIF.
- Advised Tishman Speyer on major transactions.
- Advising AEW Invest on the sale of the entire portfolio of the German Cities Office fund (selection portfolio) to the British investment manager Tristan Capital Partners.
Germany > Consumer goods and food law Tier 4
Headed by Frankfurt-based life sciences expert Ulf Grundmann, King & Spalding LLP's practice advises leading global manufacturers in the food, pharmaceutical and dietary supplement sectors on regulatory and competition law issues as well as in court proceedings. Health-related advice, particularly at the interface between food law and pharmaceuticals, represents one central pillar of the practice as well as disputes pertaining to the health claims regulation. Frankfurt's cooperation with the firm's Washington office as well as its strong transatlantic food law practice is also of note; clients are also often supported across European borders.Practice head(s):
Key clients
Novartis
ratiopharm
GlaxoSmithKline Consumer Healthcare GmbH & Co. KG (GSK Consumer Healthcare)
Famous Brands GmbH
Angelini Pharma Deutschland GmbH
Pfizer Consumer Healthcare
Amy’s Kitchen
Gamers Only GmbH
Dr. Willmar Schwabe GmbH & Co.KG
Teva Deutschland GmbH
Teva Pharmaceuticals B.V.
Deutsche Homöopathie-Union DHU-Arzneimittel GmbH & Co. KG (DHU)
Chemische Fabrik Kreussler Co. GmbH
Daizu GmbH
Dr. Kade Pharmazeutische Fabrik GmbH
VSM Geneesmiddelen B.V.
SGF International e.V.
Eckes- Granini Group
Truw Arzneimittel Gmb
biomo-vital GmbH
Work highlights
- Representation of GlaxoSmithKline Consumer Healthcare GmbH & Co. KG (GSK Consumer Healthcare) in competition law disputes regarding OTC products in connection with food, drug and medical device law.
- Advising Amy’s Kitchen on food law in the EU and the US.
- Advising Famous Brands on food law and regulatory issues and representation in a competition law dispute in connection with a melatonin-containing food.
Dispute resolution > Arbitration (including international arbitration) Tier 4
Led by data protection expert and arbitrator Jan Schäfer, King & Spalding LLP's arbitration team handles investment and energy arbitrations, while specializing in advising on energy charter proceedings related to the retrospective reduction of feed-in tariffs. The group frequently represents investors, often in cooperation with offices across the firm's global network. Associate Sebastian Müller is also well versed in data protection and also acts as sole arbitrator.Practice head(s):
Other key lawyers:
Testimonials
‘Jan Schäfer is a top arbitrator.’
‘Good team, particularly active in energy arbitration and investment disputes. Part of a very strong international arbitration practice.’
‘Jan Schäfer: Very experienced, especially in the area of investment disputes and energy law disputes.’
‘Dr. Jan Schäfer is an excellent chairman in arbitration negotiations. He stays calm even in the most difficult proceedings and does not show any signs of fatigue, even during 14-hour negotiation days. In addition, he is excellently prepared. It was a pleasure.’
‘Jan Schäfer is an outstanding, highly experienced lawyer in international arbitration. Personally very pleasant to deal with. Excellent, sensitive arbitrator.’
Key clients
Doosan
DCM Energy GmbH & Co. Solar 1 KG
ESPF Beteiligungs GmbH, ESPF Nr. 2 Austria Beteiligungs GmbH und InfraClass Energie 5 GmbH & Co. KG
KS Invest GmbH und TLS Invest GmbH
Work highlights
- Representing several investors in an ICSID proceeding regarding the violation of the Energy Charter Treaty by Spain due to retrospective reduction of guaranteed feed-in tariffs for renewable energies.
- Representing DCM Energy GmbH & Co. Solar 1 KG in ICSID proceedings regarding the violation of the Energy Charter Treaty by Spain due to retrospective reduction of guaranteed feed-in tariffs for renewable energies.
King & Spalding LLP > Firm Profile
The firm: Celebrating more than 130 years of service, King & Spalding is a global law firm that represents a broad array of clients, including half of the Fortune Global 100, with 1,200 lawyers in 23 offices in the United States, Europe, the Middle East and Asia.
The firm has handled matters in over 160 countries on six continents and is consistently recognised for the results it obtains, its uncompromising commitment to quality and its dedication to understanding the business and culture of its clients.
Main Contacts
Department | Name | Telephone | |
---|---|---|---|
Chairman | Robert D Hays | ||
Managing Partner, Frankfurt office | Axel Schilder |
Lawyer Profiles
Photo | Name | Position | Profile |
---|---|---|---|
![]() | Ulf Grundmann | Ulf Grundmann is Partner of King & Spalding’s FDA & Life Sciences… | View Profile |
![]() | Mr Jan Schäfer | Jan K. Schäfer heads the dispute resolution practice in Germany. As a… | View Profile |
![]() | Mr Jan Schäfer | Jan K. Schäfer heads the dispute resolution practice in Germany. As a… | View Profile |
Staff Figures
Number of lawyers : 1200+ firmwideOther
Other offices : Abu Dhabi, Atlanta, Austin, Brussels, Charlotte, Chicago, Denver, Dubai, Geneva, Houston, London, Los Angeles, Miami, New York, North Virginia, Paris, Riyadh, San Francisco, Silicon Valley, Singapore, Tokyo, Washington, D.C.Legal Briefings
Assisting clients in the present and anticipating the future
2022 is a pivotal year We are going through unprecedented crises requiring a major evolution of our society. One of King & Spalding’s strengths is to be at the side of our client in this context. So far, more than 330m people have contracted the Covid-19 virus, all variants combined, and at least 6m have …